Data updated: Mar 10, 2026
CORLANOR
IVABRADINE HYDROCHLORIDE
Approved 2015-04-15
2
Indications
--
Phase 3 Trials
2
Priority Reviews
10
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2015-04-15
- Routes
- ORAL
- Dosage Forms
- TABLET, SOLUTION
CORLANOR Approval History
Loading approval history...
What CORLANOR Treats
2 FDA approvalsOriginally approved for its first indication in 2015 . Covers 2 distinct patient populations.
- Other (2)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CORLANOR FDA Label Details
ProCORLANOR Patents & Exclusivity
Latest Patent: Jun 2027
Exclusivity: Oct 2026
Patents (36 active)
US7867996*PED
Expires Jun 12, 2027
US7867996
Expires Dec 12, 2026
US7879842*PED
Expires Aug 22, 2026
US7361649*PED
Expires Aug 22, 2026
US7361650*PED
Expires Aug 22, 2026
US7361649
Expires Feb 22, 2026
US7879842
Expires Feb 22, 2026
US7361650
Expires Feb 22, 2026
+ 26 more patents
Exclusivity
ODE-234
Until Apr 2026
PED
Until Oct 2026
Source: FDA Orange Book
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.